Strength Training Intensity for Osteoporosis
Trial Summary
What is the purpose of this trial?
Osteoporosis is a bone disease that can result in fractures, disability and an increased risk of premature death. Exercise is recommended for fall and fracture prevention, but health care professionals often recommend walking or lower intensity community exercise classes, which may not be effective for building bone. Further, individuals with osteoporosis are often told to avoid lifting or moving in certain ways, which creates fear and activity avoidance. Conversely, research suggests that to stimulate bone, you need higher loads on bone, with either higher intensity resistance training or impact exercise - the types of things people with low bone mass are told to avoid. Our study will examine different types of exercise intensity and how they translate to building bone in people with low bone mineral density (BMD).
Will I have to stop taking my current medications?
The trial requires that participants have not taken medications affecting bone health in the last 12 months. If you are currently on such medications, you may need to stop taking them to participate.
What data supports the effectiveness of the treatment Strength Training Intensity for Osteoporosis?
Research shows that high-load resistance training and power-based resistance training can improve bone mineral density (BMD) and reduce fall risk in postmenopausal women with osteoporosis. Additionally, maximal strength training has been found to enhance skeletal health by increasing bone mineral content and stimulating bone formation.12345
Is strength training generally safe for humans?
How does supervised strength training differ from other treatments for osteoporosis?
Supervised strength training is unique because it involves high-intensity exercises specifically designed to improve bone density and muscle strength, which are crucial for reducing fracture risk in osteoporosis. Unlike other treatments that may focus on medication, this approach uses physical activity to directly target bone health and muscle function.111121314
Eligibility Criteria
This trial is for individuals over 50 with low bone density or high fracture risk who have declined osteoporosis medication. Participants must be postmenopausal, willing to exercise twice weekly, and fully vaccinated against COVID-19. Those already doing similar training or with conditions affecting bone health cannot join.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants engage in supervised twice-weekly progressive resistance training at moderate or high intensity, or a home posture and balance exercise program for one year
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Home exercise (Exercise)
- Supervised strength training (group 1) (Behavioural Intervention)
- Supervised strength training (group 2) (Behavioural Intervention)